8 clinical trials registered, 3 recruiting. Interventions under study include other interventions, drug therapy, and gene therapy. Pipeline includes 1 PHASE4, 1 PHASE1, 3 NA. Research is sponsored by a mix of industry and academic institutions.

28 publications have been identified in PubMed for acute myeloid leukemia with minimal differentiation. Research spans Basic Science / Preclinical (36%), Gene Therapy / Novel Therapeutics (18%), and Case Report / Case Series (14%).

Recent Publications

• Smetana K (2026). [PMID: 41980000](https://pubmed.ncbi.nlm.nih.gov/41980000/). *Folia Biol (Praha)*. [Other]

• Kamitori T (2026). [PMID: 42056531](https://pubmed.ncbi.nlm.nih.gov/42056531/). *Leukemia*. [Basic Science / Preclinical]

• Wei Q (2026). [PMID: 41262054](https://pubmed.ncbi.nlm.nih.gov/41262054/). *Haematologica*. [Case Report / Case Series]

• Hervet P (2026). [PMID: 41117492](https://pubmed.ncbi.nlm.nih.gov/41117492/). *Cytopathology : official journal of the British Society for Clinical Cytology*. [Case Report / Case Series]

• Qiu R (2026). [PMID: 41915675](https://pubmed.ncbi.nlm.nih.gov/41915675/). *PLoS One*. [Basic Science / Preclinical]

• Komori T (2026). [PMID: 41631723](https://pubmed.ncbi.nlm.nih.gov/41631723/). *British journal of haematology*. [Gene Therapy / Novel Therapeutics]

• Anvari S (2026). [PMID: 42135452](https://pubmed.ncbi.nlm.nih.gov/42135452/). *Sci Rep*. [Gene Therapy / Novel Therapeutics]

• Eser A (2025). [PMID: 40214058](https://pubmed.ncbi.nlm.nih.gov/40214058/). *Nigerian journal of clinical practice*. [Clinical Trial Publication]

• Obakachi VA (2025). [PMID: 40979648](https://pubmed.ncbi.nlm.nih.gov/40979648/). *In silico pharmacology*. [Basic Science / Preclinical]

• Zhang R (2025). [PMID: 40214882](https://pubmed.ncbi.nlm.nih.gov/40214882/). *Blood research*. [Basic Science / Preclinical]